Propanc Biopharma, Inc. (PPCB)
1.76
-0.12
(-6.38%)
USD |
NASDAQ |
Nov 18, 16:00
1.77
+0.01
(+0.57%)
After-Hours: 20:00
Propanc Biopharma Price : 1.76 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 1.610 | 1.88 | 1.610 | 1.76 | 17026.00 |
| Nov 17, 2026 | 1.91 | 1.91 | 1.79 | 1.88 | 6276.00 |
| Nov 16, 2026 | 1.88 | 1.910 | 1.75 | 1.89 | 8493.00 |
| Nov 13, 2026 | 1.98 | 1.98 | 1.91 | 1.941 | 10731.00 |
| Nov 12, 2026 | 1.90 | 1.99 | 1.780 | 1.92 | 21895.00 |
| Nov 11, 2026 | 1.855 | 1.875 | 1.81 | 1.84 | 7177.00 |
| Nov 10, 2026 | 1.745 | 1.77 | 1.65 | 1.74 | 9133.00 |
| Nov 09, 2026 | 1.76 | 1.82 | 1.692 | 1.76 | 15331.00 |
| Nov 06, 2026 | 1.70 | 1.79 | 1.65 | 1.77 | 9814.00 |
| Nov 05, 2026 | 1.83 | 1.83 | 1.630 | 1.64 | 18715.00 |
| Nov 04, 2026 | 1.77 | 1.85 | 1.76 | 1.79 | 16576.00 |
| Nov 03, 2026 | 1.750 | 1.76 | 1.65 | 1.71 | 31773.00 |
| Nov 02, 2026 | 1.96 | 1.96 | 1.72 | 1.72 | 28834.00 |
| Oct 30, 2026 | 1.91 | 2.13 | 1.79 | 1.84 | 65614.00 |
| Oct 29, 2026 | 2.14 | 2.21 | 2.10 | 2.11 | 30076.00 |
| Oct 28, 2026 | 2.46 | 2.50 | 2.09 | 2.11 | 94030.00 |
| Oct 27, 2026 | 2.24 | 2.472 | 2.21 | 2.43 | 44979.00 |
| Oct 26, 2026 | 3.00 | 3.012 | 2.21 | 2.29 | 104218.0 |
| Oct 23, 2026 | 2.78 | 2.849 | 2.505 | 2.80 | 26773.00 |
| Oct 22, 2026 | 2.882 | 2.969 | 2.74 | 2.74 | 21325.00 |
| Oct 21, 2026 | 3.10 | 3.225 | 3.10 | 3.154 | 6191.00 |
| Oct 20, 2026 | 3.077 | 3.332 | 3.077 | 3.21 | 11237.00 |
| Oct 19, 2026 | 0.323 | 0.3271 | 0.3109 | 0.317 | 225472.0 |
| Oct 16, 2026 | 0.3505 | 0.4025 | 0.325 | 0.342 | 2.052M |
| Oct 15, 2026 | 0.356 | 0.37 | 0.3345 | 0.3415 | 169010.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Immutep Ltd. | 3.25 |
| CSL Ltd. | 32.90 |
| Ceryvyn Therapeutics Ltd. | 0.028 |
| Mesoblast Ltd. | 11.64 |
| Actinogen Medical Ltd. | 0.33 |
Price Related Metrics
| Price to Book Value | 0.2448 |
| Earnings Yield | -1.60K% |
| Market Cap | 1.731M |